TradingView: JP Morgan maintains Regeneron Pharmaceuticals at Overweight, raises price target to $1050 from $950
- #news
- #headline
TradingView: JP Morgan maintains Regeneron Pharmaceuticals at Overweight, raises price target to $1050 from $950
Captured 2026-11-01 from TradingView. The archived copy is preserved so this citation survives link rot.